ES2230873T3 - Utilizacion de extractos de ginkgo biloba para preparar un medicamento destinado a tratar lña esclerosis lateral amiotrofica. - Google Patents
Utilizacion de extractos de ginkgo biloba para preparar un medicamento destinado a tratar lña esclerosis lateral amiotrofica.Info
- Publication number
- ES2230873T3 ES2230873T3 ES99936702T ES99936702T ES2230873T3 ES 2230873 T3 ES2230873 T3 ES 2230873T3 ES 99936702 T ES99936702 T ES 99936702T ES 99936702 T ES99936702 T ES 99936702T ES 2230873 T3 ES2230873 T3 ES 2230873T3
- Authority
- ES
- Spain
- Prior art keywords
- radical
- extract
- gingko
- prepare
- treat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9810187A FR2782008B1 (fr) | 1998-08-07 | 1998-08-07 | Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sclerose laterale amyotrophique |
FR9810187 | 1998-08-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2230873T3 true ES2230873T3 (es) | 2005-05-01 |
Family
ID=9529516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES99936702T Expired - Lifetime ES2230873T3 (es) | 1998-08-07 | 1999-08-06 | Utilizacion de extractos de ginkgo biloba para preparar un medicamento destinado a tratar lña esclerosis lateral amiotrofica. |
Country Status (12)
Country | Link |
---|---|
US (1) | US6524629B1 (fr) |
EP (1) | EP1102586B1 (fr) |
JP (1) | JP4510289B2 (fr) |
AT (1) | ATE281162T1 (fr) |
AU (1) | AU5170499A (fr) |
CA (1) | CA2340021C (fr) |
DE (1) | DE69921662T2 (fr) |
ES (1) | ES2230873T3 (fr) |
FR (1) | FR2782008B1 (fr) |
NO (1) | NO327733B1 (fr) |
PT (1) | PT1102586E (fr) |
WO (1) | WO2000007592A1 (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2785808B1 (fr) * | 1998-11-13 | 2002-12-06 | Aventis Laboratoire | Association riluzole et alpha-tocopherol |
FR2827518B1 (fr) * | 2001-07-17 | 2005-07-08 | Sod Conseils Rech Applic | Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sarcopenie |
JP4528490B2 (ja) * | 2002-06-25 | 2010-08-18 | 和光化学株式会社 | ギンコライド−aを含有する抗不安剤 |
WO2004074024A2 (fr) | 2003-02-19 | 2004-09-02 | Pilkington North America, Inc. | Interface d'entrainement et ensemble entrainement pour fenetre coulissante motorisee |
WO2004098519A2 (fr) * | 2003-05-02 | 2004-11-18 | Georgetown University | Extrait de ginkgo biloba en tant que traitement d'une neurotoxicite induite therapeutiquement |
WO2006004386A1 (fr) * | 2004-07-02 | 2006-01-12 | Rojas Castaneda Patricia | Utilisation d'un extrait de ginkgo biloba permettant la preparation d'un medicament traitant la maladie de parkinson |
WO2007041611A2 (fr) * | 2005-09-30 | 2007-04-12 | Kinemed, Inc. | Synthèse de microtubules comme biomarqueur |
WO2007081910A2 (fr) * | 2006-01-05 | 2007-07-19 | Kinemed, Inc. | Compositions et procédés de traitement de maladies motoneuronales utilisant des modulateurs |
FR2904222A1 (fr) * | 2006-07-27 | 2008-02-01 | Sod Conseils Rech Applic | Utilisation d4extraits de ginkgo biloba pour le traitement de maladies mitochondriales |
CN102099687A (zh) * | 2008-05-21 | 2011-06-15 | 金尼医疗公司 | 使用调节剂治疗运动神经元疾病的组合物和方法 |
GB0922064D0 (en) | 2009-12-17 | 2010-02-03 | Pilkington Group Ltd | Soda lime silica glass composition |
JP6153232B2 (ja) * | 2012-01-17 | 2017-06-28 | 国立大学法人京都大学 | 筋萎縮性側索硬化症の予防および治療薬とそのスクリーニング方法 |
WO2016114655A1 (fr) * | 2015-01-12 | 2016-07-21 | Ry Pharma B.V. | Traitement de maladie neuromusculaire ou neurologique par réduction de la surstimulation des neurotransmetteurs inhibiteurs gabaergiques et/ou glycinergique |
WO2017065602A1 (fr) * | 2015-10-13 | 2017-04-20 | Ry Pharma B.V. | Traitement de maladie neuromusculaire ou neurologique par réduction de la surstimulation des neurotransmetteurs inhibiteurs gabaergiques et/ou glycinergiques |
CN108096243B (zh) * | 2017-11-24 | 2020-05-29 | 江苏康缘药业股份有限公司 | 银杏内酯组合物的医药用途 |
CN110893183A (zh) * | 2018-09-13 | 2020-03-20 | 成都百裕制药股份有限公司 | 银杏萜内酯在制备预防、缓解或治疗肌萎缩侧索硬化药物中的应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3338995A1 (de) * | 1983-10-27 | 1985-05-09 | Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe | Bilobalid enthaltende arzneimittel |
DE3940094A1 (de) * | 1989-12-04 | 1991-06-06 | Montana Ltd | Wirkstoffkonzentrate und neue wirkstoff-kombinationen aus blaettern von ginkgo biloba, ein verfahren zu ihrer herstellung und die wirkstoff-konzentrate bzw. die wirkstoff-kombinationen enthaltenden arzneimittel |
DE4328374A1 (de) * | 1993-08-24 | 1995-03-02 | Deinlein Kalb Hans | Neue Verwendung eines Extraktes aus den Blättern von Ginkgo biloba |
CZ293360B6 (cs) * | 1995-10-26 | 2004-04-14 | Sanofi-Synthelabo | Léčivo pro léčení amyotrofické laterální sklerózy |
-
1998
- 1998-08-07 FR FR9810187A patent/FR2782008B1/fr not_active Expired - Fee Related
-
1999
- 1999-08-06 AU AU51704/99A patent/AU5170499A/en not_active Abandoned
- 1999-08-06 CA CA002340021A patent/CA2340021C/fr not_active Expired - Fee Related
- 1999-08-06 PT PT99936702T patent/PT1102586E/pt unknown
- 1999-08-06 WO PCT/FR1999/001948 patent/WO2000007592A1/fr active IP Right Grant
- 1999-08-06 ES ES99936702T patent/ES2230873T3/es not_active Expired - Lifetime
- 1999-08-06 DE DE69921662T patent/DE69921662T2/de not_active Expired - Lifetime
- 1999-08-06 US US09/744,464 patent/US6524629B1/en not_active Expired - Lifetime
- 1999-08-06 EP EP99936702A patent/EP1102586B1/fr not_active Expired - Lifetime
- 1999-08-06 JP JP2000563277A patent/JP4510289B2/ja not_active Expired - Fee Related
- 1999-08-06 AT AT99936702T patent/ATE281162T1/de active
-
2001
- 2001-02-06 NO NO20010627A patent/NO327733B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO327733B1 (no) | 2009-09-14 |
CA2340021A1 (fr) | 2000-02-17 |
AU5170499A (en) | 2000-02-28 |
FR2782008B1 (fr) | 2003-04-25 |
DE69921662D1 (de) | 2004-12-09 |
WO2000007592A1 (fr) | 2000-02-17 |
EP1102586A1 (fr) | 2001-05-30 |
EP1102586B1 (fr) | 2004-11-03 |
CA2340021C (fr) | 2009-09-15 |
FR2782008A1 (fr) | 2000-02-11 |
NO20010627D0 (no) | 2001-02-06 |
PT1102586E (pt) | 2005-02-28 |
JP4510289B2 (ja) | 2010-07-21 |
DE69921662T2 (de) | 2005-10-20 |
JP2002522387A (ja) | 2002-07-23 |
NO20010627L (no) | 2001-02-06 |
US6524629B1 (en) | 2003-02-25 |
ATE281162T1 (de) | 2004-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2230873T3 (es) | Utilizacion de extractos de ginkgo biloba para preparar un medicamento destinado a tratar lña esclerosis lateral amiotrofica. | |
IE891850L (en) | Capsaicin analgesic | |
ES2241063T3 (es) | Tratamiento de la osteoartritis mediante la administracion de poli-n-acetil-d-glucosamina. | |
KR20100094981A (ko) | 간염치료용 실리비닌 성분 | |
AR030039A1 (es) | Composicion farmaceutica que comprende una droga inhibidora selectiva de la ciclooxigenasa-2, su uso en la fabricacion de un medicamento para tratar o prevenir afecciones mediadas por la ciclooxigenasa-2 y metodo para hacer dicho medicamento | |
KR970061244A (ko) | 치매 치료용 약학 조성물 | |
DE69726255D1 (de) | Verwendung von valaciclovir zur herstellung eines arzneimittels zur behandlung von genitalherpes durch einmal tägliche verabreichung | |
JP4390428B2 (ja) | 含カルシウム組織強化剤 | |
US6936285B1 (en) | Use of Ginkgo biloba extracts for preparing a medicine | |
AR046410A1 (es) | Composiciones farmaceuticas para la liberacion modificada de modafinilo | |
CA2427195A1 (fr) | Compositions de metformine a liberation controlee | |
WO2001012204A2 (fr) | Compositions et procede de traitement de l'intoxication a l'acetaminophene | |
AU2002334001B2 (en) | Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia | |
US20070178141A1 (en) | Vitamin B12 compositions | |
BRPI0413374A (pt) | composições para liberação de base fraca por um perìodo estendido de tempo | |
JPH07118148A (ja) | 肝癌予防剤 | |
JPH06502428A (ja) | デキストロメトルファン鎮咳組成物 | |
JP2009507071A (ja) | ビタミンb12組成物 | |
ITMI960736A1 (it) | Composizione farmaceutica per la terapia orale diuretica ed antiipertensiva. | |
AR020167A1 (es) | Metodo para la prevencion del inicio del asma | |
CA2193838A1 (fr) | Moyen prophylactique/remede contre certaines maladies | |
JPS6442430A (en) | Side effect remover for chemotherapeutic agent | |
JPH06321792A (ja) | 副作用軽減剤 | |
MY106032A (en) | New pharmaceutical compositions & new pharmaceutical products allowing the regeneration of leukocytes & their use in the treatment of acquired immuno-deficient syndrom | |
US8097287B2 (en) | Use of a Ginkgo biloba extract for the treatment of mitochondrial disease of genetic origin |